Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 22-01-2013 | Practice Area: | Equity Capital Markets |
| Deal Title: | Onyx Pharmaceuticals Common Stock Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated and Barclays Capital Inc. as underwriters in connection with an SEC-registered offering of 4,400,000 shares of common stock of Onyx Pharmaceuticals, Inc. for approximately USD350 million.
The Davis Polk corporate team included partner Bruce K. Dallas and associates Christopher J. Kodama, Emily Roberts and Jeffrey Hedrick. The tax team included partner Rachel D. Kleinberg, associate Rachel Lerner and law clerk Joseph Pahl. The intellectual property team included associate Bruce Rose-Innes and law clerk Dan Karmel. Elizabeth J. Gordon and Cassandra Aguirre were the legal assistants on the transaction. All members of the Davis Polk team are based in the Menlo Park and New York offices.
|
||
| Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Davis Polk |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NYSE: |
Lawyer | Bruce K Dallas |
